MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Award Announcements & Progress Reports: Federal Contracts, Grants & Cooperative Agreements
2025: Pentagon awards multiple companies $200M contracts for AI tools
Anthropic PBC
Organization & Developments: Anthropic
Parents
Anthropic PBC
Children
* Its research interests span multiple areas including natural language, human feedback, scaling laws, reinforcement learning, code generation, and interpretability.
* The initial product from the company is Claude, an AI helper for tasks of any size.
*Anthropic is an AI safety and research company that builds reliable, interpretable, and steerable AI systems.
*Anthropic is an AI-driven research company that focuses on increasing the safety of AI systems.
*Its interdisciplinary team has experience across ML, physics, policy, and product to generate research and create reliable, beneficial AI systems.
2023: DARPA holds contest for AI tools to boost cybersecurity
2024: Amazon Is Building a Mega AI Supercomputer With Anthropic
2025: AI companies see openings to improve federal, defense operations
2025: AI startup Anthropic to build out public sector team
2026: Anthropic disables Fable 5, Mythos 5 after U.S. government cites security concerns
2026: Anthropic enters drug discovery
2026: Anthropic focuses $200M in grant funding on healthcare
2026: Anthropic forms $200 million partnership with the Gates Foundation
2026: Anthropic joins OpenAI's push into health care with new Claude tools
2026: Anthropic Says Claude Hacked 3 Organizations During Cybersecurity Tests
2026: Anthropic Swings to Profit as Q2 Revenue Explodes 1,360%, Fueling IPO Hype
2026: Anthropic’s biggest healthcare bets: 8 key moves
2026: Anthropic’s new AI model cut drug design time 10x
2026: Anthropic’s New Product Aims to Handle the Hard Part of Building AI Agents | WIRED
2026: Big Tech Targets Drug Discovery with Wave of Life Science Platforms
2026: Inference inflection - Anthropic is forging its own path into life sciences, having recently drawn attention for acquiring Coefficient Bio, a roughly 10-person AI drug discovery start-up founded by former Genentech scientists, for $400 million. The OpenAI competitor has also been building Claude for Life Sciences, the AI assistant specialized for researchers, clinical coordinators, and regulatory affairs managers ...
2026: OpenAI and Anthropic are making their play for healthcare, and we're not surprised
2026: The Awesome and Alarming A.I. Visions of Anthropic’s C.E.O.
Claude
Jumps
Finance & Acquisition: Anthropic
Key People: Anthropic